ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Icosavax raises funding to advance RSV/hMPV vaccine programme pharmaceutical-technology
April 08, 2021Icosavax has raised $100m through a Series B financing round to support the development of its bivalent respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) vaccine programme through initial clinical studies.
Pharma Sources Insight January 2025
